Dentsply Sirona (XRAY) delivered mixed results in Q2 FY2026 on revenue of $898.0M versus the $889.9M estimate (-4.1% YoY) and EPS of $0.52. The next Dentsply Sirona (XRAY) earnings date is Nov 5, 2026. Below is the full Dentsply Sirona earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
$898.0M (vs $889.9M est · +0.9% surprise · -4.1% YoY)
EPS
$0.52 (vs $0.35 est · +49.4% surprise · -178.3% YoY)
Share price
$9.41 (-0.9%)
Market cap
$1.9B
Dentsply Sirona (XRAY) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q3 FY2026
$898.0M vs $889.9M est
$0.52 vs $0.35 est
+49.4%
-12.0%
Mixed
Q2 FY2026
$880.0M vs $841.8M est
$0.27 vs $0.28 est
-3.6%
-0.5%
Mixed
Q1 FY2026
$961.0M vs $926.2M est
$0.27 vs $0.28 est
-3.6%
+14.7%
Mixed
Q4 FY2025
$904.0M vs $927.1M est
$0.37 vs $0.45 est
-17.8%
-11.4%
Miss
Q3 FY2025
$936.0M vs $904.6M est
$0.52 vs $0.50 est
+4.0%
-5.3%
Beat
Q2 FY2025
$879.0M vs $920.2M est
$0.43 vs $0.29 est
+48.3%
+15.6%
Mixed
Q1 FY2025
$905.0M vs $901.3M est
$0.26 vs $0.47 est
-44.7%
-12.0%
Mixed
Q4 FY2024
$951.0M vs $937.0M est
$0.50 vs $0.48 est
+4.2%
-25.5%
Mixed
Top institutional holders
Holder
% outstanding
Shares
Value
QoQ change
Blackrock, INC.
13.4%
26.7M
$283.4M
+38.7%
Fuller & Thaler Asset Management, INC.
6.4%
12.7M
$134.7M
-0.7%
Vanguard Portfolio Management LLC
5.9%
11.8M
$125.0M
+11.9%
Aqr Capital Management LLC
5.2%
10.5M
$110.2M
+163.8%
State Street Corp
4.6%
9.3M
$98.5M
+28.2%
Vanguard Capital Management LLC
4.5%
9.0M
$96.0M
+0.5%
Lazard Asset Management LLC
4.1%
8.3M
$87.7M
+23.1%
Ariel Investments, LLC
4.0%
8.0M
$85.2M
+25.7%
Southpoint Capital Advisors LP
3.5%
7.0M
$74.3M
-30.0%
Cooke & Bieler LP
3.5%
6.9M
$73.5M
-11.2%
Recent insider transactions
Insider
Role
Date
Type
Shares
Value
MAZELSKY JONATHAN JAY
director
2026-09-30
Buy
3K
—
Fortson John C.
officer: EVP & CFO
2026-08-10
Buy
104K
$1.3M
Fortson John C.
officer: EVP & CFO
2026-08-10
Buy
24K
—
Frohning Andrea L.
officer: SVP, CHRO
2026-08-07
Sell
802
$9720
Fortson John C.
officer
2026-07-20
Other
0
—
MAZELSKY JONATHAN JAY
director
2026-06-30
Buy
3K
—
MAZELSKY JONATHAN JAY
director
2026-06-12
Buy
10K
$101400
Barton-Brobst Lindi Rene
officer: SVP, GC & Secretary
2026-06-08
Other
0
—
What you'll find
Next Dentsply Sirona (XRAY) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Dentsply Sirona reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Dentsply Sirona (XRAY)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Dentsply Sirona's next earnings date?
Dentsply Sirona's (XRAY) next scheduled earnings date is Nov 5, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Dentsply Sirona (XRAY) beat or miss earnings?
In Q2 FY2026, Dentsply Sirona (XRAY) posted mixed results — revenue of $898.0M versus the $889.9M estimate (+0.9% surprise) and EPS of $0.52 versus $0.35 expected (+49.4% surprise). Magnisto decodes every Dentsply Sirona (XRAY) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does Dentsply Sirona beat earnings estimates?
Over its last 8 reported quarters, Dentsply Sirona (XRAY) beat Wall Street EPS estimates 4 times, most recently a mixed result in Q3 FY2026. Magnisto tracks every Dentsply Sirona (XRAY) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does Dentsply Sirona stock move after earnings?
Over its last 8 quarterly reports, Dentsply Sirona (XRAY) moved an average of ±12.1% the day after earnings — ranging from -25.5% (Q4 FY2024) to +15.6% (Q2 FY2025). The stock rose after 2 of those 8 reports and fell after 6. Heading into its next report on Nov 5, 2026, options-implied volatility is pricing in a move of roughly ±7.7% (derived). Magnisto tracks the realized post-earnings move for every Dentsply Sirona (XRAY) quarter alongside the beat/miss verdict — past moves don't predict the next one.
Who are the largest shareholders of Dentsply Sirona?
Institutions hold about 114.2% of Dentsply Sirona's (XRAY) shares outstanding as of the 2026-06-30 13F quarter. Its largest institutional holders include Blackrock, INC. (13.4%), Fuller & Thaler Asset Management, INC. (6.4%), Vanguard Portfolio Management LLC (5.9%). Magnisto lists Dentsply Sirona's (XRAY) top 13F holders with each stake size and its quarter-over-quarter change.
Are insiders buying or selling Dentsply Sirona (XRAY)?
In the most recent Form 4 filings Magnisto tracks, Dentsply Sirona (XRAY) insiders recorded 5 purchases and 1 sale — net buying. Insider transactions are one signal among many and are often routine (option exercises or scheduled 10b5-1 sales), so Magnisto shows the raw feed for you to judge.
What is the forecast for Dentsply Sirona (XRAY) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Dentsply Sirona (XRAY), anchored to the current $9.41 share price, so you can weigh the bull, base and bear cases for Dentsply Sirona side by side.
Is Dentsply Sirona (XRAY) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Dentsply Sirona fits your own thesis and risk profile. This is research, not investment advice.